Heparin-PF4 Antibody (HIT)
Heparin induced antibody is used to diagnose heparin induce thrombocytopenia (HIT). HIT is an immunologic adverse effect of heparin therapy which results in development of antibody to a patient’s own platelets. This results in decreased platelet count. HIT develops in up to 5% of patients treated with heparin therapy. A decline from a baseline of approximately 50% platelet count within 5 days of treatment is typically noted. The antibody develops due to the body’s recognition of the combination of heparin attached to platelet factor 4 (PF4) located on the surface of the platelet. Normally the antibody disappears after heparin is discontinued and consequently testing should be performed during the acute stages.
Patients with this disease should be permanently discontinued from heparin therapy and treated with another anticoagulant such as danaparoid, hirudin, or argatroban. This test is used to diagnose the cause of thrombosis or thrombocytopenia in patients on heparin therapy. Enzyme Linked Immunosorbent Assay (ELISA) offers rapid and sensitive detection; however, Serotonin Release Assay (SRA) has high sensitivity and specificity and is usually considered the gold standard. Assays either measure antibody binding to PF4/heparin complexes or detect heparin-dependent platelet activation by patient serum. The diagnosis of HIT usually requires the combination of pretest probability (clinical assessment) and a positive test for platelet activating antibodies. Pre-test 4Ts score (4T score <3 points) predicts a negative laboratory assay. Combining the clinical score with a laboratory test for HIT provides better sensitivity and specificity for HIT.
- Determine etiology of thrombosis or thrombocytopenia in patients on heparin therapy
Increased in:
- Antibodies are present and the test is positive in heparin-induced thrombocytopenia
- Might be present in some other anti-platelet autoimmune disorders not induced by heparin therapy
Negative (Non-reactive)
Enzyme Linked Immunosorbent Assay, Platelet Aggregation Assay, Serotonin Release Assay.
Plasma Citrate (Light Blue), Serum (SST) or Plasma EDTA (Lavender).
Stability
- Ambient: Unacceptable
- Refrigerated: 48 hours
- Frozen: 6 months
Platelet Count, Activated Partial Thromboplastin Time, Prothrombin Time/INR, von Willebrand Factor, CBC.
1-3 days.
- Am J Med. 2012 Jan;125(1):44-9. [PMID: 22075045]
- J Thromb Haemost. 2009 Jul;7 Suppl 1:9-12. [PMID: 19630757]
- Int J Hematol. 2002 Aug;76 Suppl 1:346-51. [PMID: 12430880]
- Blood. 1998 Nov 1;92(9):3250-9. [PMID: 9787161]
- Jacobs DS and DeMott WR. Laboratory Test Handbook. 5th. Hudson, OH. Lexi-Comp, Inc (2001).